The Coalition is always on the lookout for changes in policy and current events that could impact the health status of LGBTQ+ individuals, or influence access to and utilization of health care within the LGBTQ+ community. These Advocacy Briefs summarize recent news items, along with specific action steps you can take to advocate for LGBTQ+ health equity.
Comments on HRSA’s proposed 340B Rebate Model Pilot Program.
The Trump Administration released the President’s Fiscal Year 2027 budget, which sets its funding priorities for the coming year. While the proposed budget maintains funding for HIV care and treatment, it does so without additional investment in these proven interventions.
Comments on CMS’ Draft Guidance for the Medicare Drug Price Negotiation Program (IPAY2028).
The Supreme Court’s decision leaves patients less protected by clinical standards and more exposed to claims framed as protected speech—raising new questions about how those standards can be enforced at all.
HealthHIV supports the proposed update to the Ryan White Part A and B formula calculations, with important implementation considerations.
This comment on Docket No. CDC-2025-0783 focuses on ACIP’s December agenda—specifically the Hepatitis B birth-dose discussions, possible changes to the childhood and adolescent schedule, and the implications for VFC coverage. It also addresses the committee’s recent restructuring and reduced transparency in Work Group processes, and the downstream effects on vaccine access, HIV and viral hepatitis…
On behalf of HealthHIV and the National Coalition for LGBTQ Health, this comment on Docket No. CDC-2025-0454 addresses ACIP membership changes, agenda items on COVID-19, Hepatitis B, MMRV, RSV, and Vaccines for Children, and the implications for vaccine access, HIV, viral hepatitis, immune deficiency care, and older adult health.
House Republicans’ FY26 budget bill would eliminate all federal HIV prevention funding, cut the Ryan White Program by 20% ($525M), collapse STI and viral hepatitis funding into block grants, and dismantle decades of bipartisan progress in HIV care, prevention, and public health.
Comments on proposed changes to the Personal Responsibility and Work Opportunity Reconciliation Act of 1996.
Comments regarding Medicare Drug Price Negotiation Program draft guidance.
A fact sheet regarding upcoming Medicare Cost Smoothing.
Comments on proposed changes to the Medicare Advantage and Prescription Drug Plans Bid Pricing Tool.